Start Date
March 31, 2011
Primary Completion Date
June 30, 2011
ACZ885
Placebo
Aurora St Luke's Medical Center, Endocrine & Diabetes Center, Milwaukee
LMC Endocrinology Centres (Barrie) Ltd, Barrie
LMC Endocrinology Centres (Bayview) Ltd, Toronto
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Hanover
Novartis Investigative Site, Neuwied
Novartis Investigative Site, Bristol
Novartis Investigative Site, Exeter
Novartis Investigative Site, Hull
Novartis Investigative Site, Liverpool
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY